47 unknown. 47 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 47 | Unknown 47 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps Dupilumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | Dr. Andrew Thamboo, MD | 60 | 2024-08-01 | 2024-08-16 |
| Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment Mepolizumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | St. Paul's Sinus Centre | 90 | 2023-07-01 | 2024-04-17 |
| Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma Azithromycin, ICS/LABA - Asthma, Chest Syndrome | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 248 | 2023-01-01 | 2022-11-04 |
| Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma Salmeterol Xinafoate, Salmeterol Fluticasone - Asthma | Phase 4 | Unknown | Imperial College London | 24 | 2021-07-23 | 2023-04-25 |
| Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients. anti IL5 receptor antibodies - Severe Asthma | Phase 4 | Unknown | Scarlata, Simone, M.D. | 80 | 2021-03-18 | 2021-08-12 |
| Effect of Dupilumab on Aspirin Intolerance Dupilumab - AERD - Aspirin Exacerbated Respiratory Disease | Phase 4 | Unknown | Medical University of Vienna | 30 | 2020-06-01 | 2022-04-06 |
| The Efficacy of Budesonide/Formoterol in Cough Variant Asthma budesonide/formoterol - Cough Variant Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 500 | 2020-05-01 | 2020-05-12 |
| Anti-viral Effects of Azithromycin in Patients With Asthma and COPD Azithromycin, Placebo oral tablet - Asthma, COPD | Phase 4 | Unknown | Bispebjerg Hospital | 100 | 2020-03-02 | 2021-07-26 |
| Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children probiotics, conventional medical treatment - Rhinitis, Allergic, Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-03-01 | 2021-06-24 |
| A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil Mepolizumab 100 MG [Nucala] - Eosinophilic Asthma | Phase 4 | Unknown | University of Sao Paulo General Hospital | 18 | 2020-01-09 | 2020-01-14 |
| Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications Foster - Asthma | Phase 4 | Unknown | Far Eastern Memorial Hospital | 200 | 2020-01-01 | 2019-12-04 |
| Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma. Randomisation to omalizumab, Randomisation to mepolizumab - Severe Asthma | Phase 4 | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 100 | 2019-05-10 | 2022-10-27 |
| Diesel Exhaust Induces Glucocorticoid Resistance Placebo, Budesonide, Filtered Air - Exposure to Pollution, Glucocorticoid Resistance | Phase 4 | Unknown | University of British Columbia | 30 | 2018-12-01 | 2024-07-24 |
| Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". Mepolizumab, Omalizumab - Asthma, Eosinophilic Asthma | Phase 4 | Unknown | University of Newcastle, Australia | 200 | 2018-11-03 | 2020-10-14 |
| Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO) Budesonide(160ug) and Formoterol(4.5ug) bid - Pulmonary Disease, Chronic Obstructive, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | Phase 4 | Unknown | Zhujiang Hospital | 80 | 2018-06-20 | 2018-06-27 |
| Inhaler Technique in Elderly Patients: Impact on Disease Exacerbations Inhaler technique education - Asthma, COPD | Phase 4 | Unknown | Aveiro-Aradas Family Health Unit | 146 | 2018-06-01 | 2018-02-28 |
| The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers Probiotic Formula, Placebo Oral Capsule - Asthma Occupational | Phase 4 | Unknown | University of Sao Paulo | 200 | 2017-01-01 | 2017-01-13 |
| Low Exhaled NO and ICS in Suspected Asthma Budesonide (Pulmicort), Placebo - dummy inhaler - Asthma | Phase 4 | Unknown | University of Nottingham | 165 | 2016-05-01 | 2016-05-13 |
| Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients budesonide 160μg/formoterol 4.5μg - Bronchial Asthma | Phase 4 | Unknown | Zhujiang Hospital | 30 | 2015-09-01 | 2016-10-17 |
| Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Nebulized Magnesium Sulfate, Nebulized isotonic saline, Nebulized Salbutamol - Asthma | Phase 4 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 152 | 2015-09-01 | 2015-12-02 |
Showing 20 of 47. Sign in to see all of them.
Cough-Variant Asthma (6) · Pulmonary Disease, Chronic Obstructive (3) · Pulmonary Eosinophilia (3) · Rhinitis, Allergic (2) · Asthma, Occupational (1) · Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (1) · Bronchial Diseases (1) · Dermatitis, Atopic (1) · Gastroesophageal Reflux (1) · Glucocorticoid Receptor Deficiency (1) · Hypersensitivity (1) · Immune System Diseases (1) · Inflammation (1) · Lung Diseases (1)
Respiratory Hypersensitivity (47) · Respiratory Tract Diseases (47) · Bronchial Diseases (46) · Hypersensitivity (46) · Hypersensitivity, Immediate (46) · Immune System Diseases (46) · Lung Diseases (45) · Lung Diseases, Obstructive (45) · Pathological Conditions, Signs and Symptoms (4) · Chronic Disease (3) · Disease Attributes (3) · Eosinophilia (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3)
Budesonide (5) · Budesonide, Formoterol Fumarate Drug Combination (5) · Formoterol Fumarate (4) · Omalizumab (3) · mepolizumab (3) · Albuterol (2) · Azithromycin (2) · Methacholine Chloride (2) · Salmeterol Xinafoate (2) · dupilumab (2) · Adenosine Monophosphate (1) · BID protein, human (1) · Beclomethasone (1) · Calcitriol (1) · Fluticasone-Salmeterol Drug Combination (1)
Bispebjerg Hospital (4) · Medical University of Lodz (4) · Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · The First Affiliated Hospital of Guangzhou Medical University (3) · Zhujiang Hospital (3) · All India Institute of Medical Sciences (1) · Allergy and Asthma Center of El Paso (1) · Asan Medical Center (1) · Aveiro-Aradas Family Health Unit (1) · California Allergy and Asthma Medical Group, Inc. (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Creighton University (1) · Dr. Andrew Thamboo, MD (1) · Emory University (1) · Far Eastern Memorial Hospital (1)
China (10) · United States (6) · Denmark (4) · Poland (4) · Brazil (3) · Canada (3) · Mexico (2) · Australia (1) · Austria (1) · Belgium (1) · India (1) · Italy (1) · South Korea (1) · Switzerland (1) · Taiwan (1)
Iwona Stelmach, MD, PhD, Prof (3) · Jimmi Elers, MD (3) · Albrecht Breitenbuecher, MD (1) · Ana Luisa G Fernandes, MD, PhD (1) · Andrew Thamboo (1) · Barbara P Yawn, MD MSc (1) · Benjamin D. Gold, MD. (1) · Celeste Porsbjerg, MD, PhD (1) · Charles Pilette (1) · Chris Carlsten, MD (1) · Christine Bangert, M.D. (1) · Christopher F Rider, PhD (1)
PMID 11113831, PMID 11825832, PMID 18331513, PMID 20887423, PMID 21060320, PMID 21782228, PMID 22153774, PMID 22394648, PMID 24809759, PMID 25419479, PMID 29531100, PMID 30696670, PMID 36217131, PMID 41309110
2019 (2), 2005 (1), 2017 (1)